Hong Kong Economic and Trade Office, USA
Hong Kong
News Release



HKETONY promotes Hong Kong’s advantages in biotechnology development

 

 



For more information, please contact

Melissa Ng in New York City: (212) 752 3320
Wing Yan Tong in San Francisco: (415) 835 9315

Daniel McAtee in Washington, D.C.: (202) 238 6360




June 4, 2019 - The Hong Kong Economic and Trade Office, New York (HKETONY) held a roundtable luncheon at the BIO International Convention in Philadelphia, the United States (US), today to promote Hong Kong’s opportunities and strengths in biotechnology development, and encourage biotechnology businesses in the US to leverage Hong Kong's advantages to grow.

Director of HKETONY Joanne Chu met Governor Phil Murphy of New Jersey at the 2019 BIO Convention and briefly updated him on the latest biotech development of Hong Kong.
Director of HKETONY Joanne Chu met Governor Phil Murphy of New Jersey at the 2019 BIO Convention and briefly updated him on the latest biotech development of Hong Kong.

Speaking at the Hong Kong Luncheon, the Director of the HKETONY, Ms Joanne Chu, said that Hong Kong’s appeal as a biotechnology hub continues to gain traction, with the introduction of new measures and investment by the Government. In addition, the Guangdong-Hong Kong-Macao Greater Bay Area development will bring further opportunities for the biotechnology industry in the region.

In the past two years, to support the development of innovation and technology, the Hong Kong Government has invested about US$13 billion and introduced a series of measures from infrastructure development to talent admission to tax deductions for corporation's research and development (R&D) expenditure. The Government is also enhancing its R&D capabilities by setting up two world-class research clusters in the Hong Kong Science Park, including one focusing on healthcare technologies, to give an edge in pooling top-notch universities, scientific research institutions and enterprises from all over the world to undertake R&D activities together.

Hong Kong is now the world’s second largest funding hub for biotechnology. Following the launch of new listing rules by the Hong Kong Exchanges and Clearing Limited (HKEX) in April last year to welcome pre-revenue biotechnology companies, 12 biotechnology companies, including eight pre-revenue companies, have listed in Hong Kong, raising some US$4.7 billion through initial public offerings. 

Today’s luncheon was attended by about 80 members of the biotechnology industry in the US. Other speakers included the Senior Vice President of the Markets Division at HKEX, Mr Michael Chan; the Director of the BioMedical Technology Cluster, Hong Kong Science and Technology Parks Corporation, Professor Cesar Wong; the Chairman of the Hong Kong Biotechnology Organization, Professor Albert Yu; the Director of the Hong Kong Trade Development Council in New York, Ms Anna Fan; and Associate Director-General of Invest Hong Kong Mr Charles Ng. They highlighted Hong Kong’s booming biotechnology ecosystem including listing and fund-raising opportunities, and the latest developments in the biotechnology and biomedical landscape in the city.

The Hong Kong Economic and Trade Office, New York, held a Hong Kong Luncheon in Philadelphia, the United States (US) today (June 4, Philadelphia time) to promote Hong Kong's strengths in biotechnology development. It was attended by about 80 members of the biotechnology industry in the US.
The Hong Kong Economic and Trade Office, New York, held a Hong Kong Luncheon in Philadelphia, the United States (US) today (June 4, Philadelphia time) to promote Hong Kong's strengths in biotechnology development. It was attended by about 80 members of the biotechnology industry in the US.
 
The Hong Kong Economic and Trade Office, New York, held a Hong Kong Luncheon in Philadelphia, the United States (US) today (June 4, Philadelphia time) to promote Hong Kong's strengths in biotechnology development. Pictured in the group photo are (from left to right) Senior Vice President of Hong Kong Exchanges and Clearing Limited, Mr Michael Chan; Director of BioMedical Technology Cluster, Hong Kong Science and Technology Parks Corporation, Professor Cesar Wong; Chairman of Hong Kong Biotechnology Organisation, Professor Albert Yu; Director of Hong Kong Trade Development Council in New York, Ms Anna Fan; Director of the HKETONY, Ms Joanne Chu; Director for International Affairs of Biotechnology Innovation Organization, Ms Monica He; and Associate Director-General of Invest Hong Kong, Mr Charles Ng.
The Hong Kong Economic and Trade Office, New York, held a Hong Kong Luncheon in Philadelphia, the United States (US) today (June 4, Philadelphia time) to promote Hong Kong's strengths in biotechnology development. Pictured in the group photo are (from left to right) Senior Vice President of Hong Kong Exchanges and Clearing Limited, Mr Michael Chan; Director of BioMedical Technology Cluster, Hong Kong Science and Technology Parks Corporation, Professor Cesar Wong; Chairman of Hong Kong Biotechnology Organisation, Professor Albert Yu; Director of Hong Kong Trade Development Council in New York, Ms Anna Fan; Director of the HKETONY, Ms Joanne Chu; Director for International Affairs of Biotechnology Innovation Organization, Ms Monica He; and Associate Director-General of Invest Hong Kong, Mr Charles Ng.


2019 © | Important notices       Privacy policy      Accessibility                                                                                                                                                    Last Revision Date: June 5, 2019

 

Web For All W3C Web Accessibility initiative    
This website adopts web accessibility design and conforms to the World Wide Web Consortium (W3C) Web Content Accessibility Guidelines (WCAG) 2.0 Level AA standard. Should you have any enquiries or comments on its accessibility, please contact us by phone or email.